Pharmacogenetics of asthma therapy.

Abstract excerpt

Asthma is a chronic disorder causing inflammation and reversible airway obstruction that affects approximately 300 million individuals worldwide. The incidence of asthma has nearly doubled in the past three decades resulting in higher rates of morbidity, mortality and health care costs. Despite the availability of several classes of asthma medications such as beta-agonists, leukotriene modifiers and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adrenergic beta-Agonists
• Share to Anti-Asthmatic Agents
• Share to Asthma